Latest News for: pbm

Edit

Final Determination Pursuant to Rule 128: Fair and Reasonable Pharmacy Compensation Program. Prescryptive Health, Inc., Arkansas PBM License No. 2026-50, and the health benefit plans and healthcare payors identified in Confidential Attachment A. (Arkansas Insurance Department)

Public Technologies 09 Oct 2026
Arkansas PBM License No ... Section I, Subsection I of Bulletin 18-2024 provides that a PBM of a health benefit plan may file the data or report required by the bulletin on behalf of a health benefit plan for which it administers drug benefits.
Edit

Final Determination Pursuant to Rule 128: Fair and Reasonable Pharmacy Compensation Program. Ventegra, Arkansas PBM License No. UNLICENSED, and the health benefit plans and healthcare payors identified in Confidential Attachment A. (Arkansas Insurance Department)

Public Technologies 09 Oct 2026
Arkansas PBM License No ... Section I, Subsection I of Bulletin 18-2024 provides that a PBM of a health benefit plan may file the data or report required by the bulletin on behalf of a health benefit plan for which it administers drug benefits.
Edit

Final Determination Pursuant to Rule 128: Fair and Reasonable Pharmacy Compensation Program. CarelonRx, Inc., Arkansas PBM License No. 2026-08, and the health benefit plans and healthcare payors identified in Confidential Attachment A. (Arkansas Insurance Department)

Public Technologies 09 Oct 2026
Arkansas PBM License No ... Section I, Subsection I of Bulletin 18-2024 provides that a PBM of a health benefit plan may fde the data or report required by the bulletin on behalf of a health benefit plan for which it administers drug benefits.
Edit

Final Determination Pursuant to Rule 128: Fair and Reasonable Pharmacy Compensation Program. MedOne, L.C. Arkansas PBM License No. 2026-57, and the health benefit plans and healthcare payors identified in Confidential Attachment A. (Arkansas Insurance Department)

Public Technologies 09 Oct 2026
Arkansas PBM License No ... Section I, Subsection I of Bulletin 18-2024 provides that a PBM of a health benefit plan may file the data or report required by the bulletin on behalf of a health benefit plan for which it administers drug benefits.
Edit

Final Determination Pursuant to Rule 128: Fair and Reasonable Pharmacy Compensation Program. VeracityRX, Arkansas PBM License No. UNLICENSED, and the health benefit plans and healthcare payors identified in Confidential Attachment A (Arkansas Insurance Department)

Public Technologies 07 Oct 2026
Arkansas PBM License No ... Section I, Subsection I of Bulletin 18-2024 provides that a PBM of a health benefit plan may file the data or report required by the bulletin on behalf of a health benefit plan for which it administers drug benefits.
Edit

Georgia Life Sciences Weighs In on PBM and 340B Policy (GaBio - Georgia Bio)

Public Technologies 05 Oct 2026
) ... The Study Committee continues its work this fall as it develops recommendations for the Georgia General Assembly. < Older Post. Attachments Original document Permalink. Disclaimer ... (noodl. 134953594) .
Edit

SNAPSHOT | MCMC probes AI-manipulated Mahathir content; Siti Kasim joins PBM

Malaysia Kini 02 Oct 2026
What’s going on in the news today, with updates at 2pm, 6pm, and 9pm. .
Edit

PSG Report Finds PBM Satisfaction Stabilizes, but Key Pain Points Remain

Business Wire 29 Sep 2026
For over two decades, PSG has provided independent, comprehensive research on PBM performance ...
Edit

Chairman Cassidy, Warner Introduce Bill to Improve PBM Reimbursement Data, Lower Cost of Prescription Drugs (US Senate Committee on Health, Education, Labor, and Pensions)

Public Technologies 29 Sep 2026
... surveys to include specialty and mail-order pharmacies, providing more thorough data on drug acquisition costs and helping ensure PBM reimbursement rates cover the complete cost of prescription drugs.
Edit

AMA analysis: PBM market concentration continues to rise (AMA - American Medical Association)

Public Technologies 29 Sep 2026
The findings point to the need for continued scrutiny of PBM market concentration and vertical integration, along with greater transparency and accountability for business practices that can affect prescription drug costs, competition and access.
×